000 | 01750 a2200493 4500 | ||
---|---|---|---|
005 | 20250515212041.0 | ||
264 | 0 | _c20100416 | |
008 | 201004s 0 0 eng d | ||
022 | _a1319-2442 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHelal, Imed | |
245 | 0 | 0 |
_aClinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients. _h[electronic resource] |
260 |
_bSaudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia _cMar 2010 |
||
300 |
_a262-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aEchocardiography, Doppler, Color |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xblood |
650 | 0 | 4 |
_aPeptide Fragments _xblood |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aROC Curve |
650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aUp-Regulation |
650 | 0 | 4 |
_aVentricular Dysfunction, Left _xblood |
700 | 1 | _aBelhadj, Raja | |
700 | 1 | _aMohseni, Amira | |
700 | 1 | _aBazdeh, Lilia | |
700 | 1 | _aDrissa, Habiba | |
700 | 1 | _aElyounsi, Fethi | |
700 | 1 | _aAbdallah, Taieb Ben | |
700 | 1 | _aAbdelmoula, Jaouida | |
700 | 1 | _aKheder, Adel | |
773 | 0 |
_tSaudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia _gvol. 21 _gno. 2 _gp. 262-8 |
|
999 |
_c19594663 _d19594663 |